id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-N-6373-0001,FDA,FDA-2017-N-6373,"Roxane Laboratories, Inc.; Withdrawal of Approval of a New Drug Application for ROXICODONE (Oxycodone Hydrochloride) Sustained-Release Tablets, 10 Milligrams and 30 Milligrams",Notice,Withdrawal,2017-11-29T05:00:00Z,2017,11,2017-11-29T05:00:00Z,,2017-11-29T16:30:15Z,2017-25771,0,0,0900006482cbbc78